Lai Wang - Net Worth and Insider Trading
Lai Wang Net Worth
The estimated net worth of Lai Wang is at least $792 Million dollars as of 2026-08-14. Lai Wang is the President, Global Head of R&D of BeOne Medicines Ltd and owns about 2,282,969 shares of BeOne Medicines Ltd (ONC) stock worth over $792 Million. Details can be seen in Lai Wang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lai Wang has not made any transactions after 2026-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lai Wang
Lai Wang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lai Wang owns 1 companies in total, including BeOne Medicines Ltd (ONC) .
Click here to see the complete history of Lai Wang’s form 4 insider trades.
Insider Ownership Summary of Lai Wang
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ONC | BeOne Medicines Ltd | 2026-06-23 | Global Head of R&D |
Lai Wang Latest Holdings Summary
Lai Wang currently owns a total of 1 stock. Lai Wang owns 2,282,969 shares of BeOne Medicines Ltd (ONC) as of June 23, 2026, with a value of $792 Million.
Latest Holdings of Lai Wang
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd | 2026-06-23 | 2,282,969 | 347.00 | 792,195,950 |
Holding Weightings of Lai Wang
Lai Wang Form 4 Trading Tracker
According to the SEC Form 4 filings, Lai Wang has made a total of 20 transactions in BeOne Medicines Ltd (ONC) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in BeOne Medicines Ltd is the sale of 1,068 shares on June 23, 2026, which brought Lai Wang around $295,558.
Insider Trading History of Lai Wang
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Lai Wang Trading Performance
Lai Wang Ownership Network
Ownership Network List of Lai Wang
Ownership Network Relation of Lai Wang
Lai Wang Owned Company Details
What does BeOne Medicines Ltd do?
Who are the key executives at BeOne Medicines Ltd?
Lai Wang is the Global Head of R&D of BeOne Medicines Ltd. Other key executives at BeOne Medicines Ltd include director & Chief Executive Officer John Oyler , SVP & General Counsel Chan Henry Lee , and Chief Financial Officer Aaron Rosenberg .
BeOne Medicines Ltd (ONC) Insider Trades Summary
Over the past 18 months, Lai Wang made 11 insider transaction in BeOne Medicines Ltd (ONC) with a net sale of 23,437. Other recent insider transactions involving BeOne Medicines Ltd (ONC) include a net sale of 49,060 shares made by Chan Henry Lee , a net sale of 1,328,331 shares made by John Oyler , and a net sale of 275,786 shares made by Xiaobin Wu .
In summary, during the past 3 months, insiders sold 949,389 shares of BeOne Medicines Ltd (ONC) in total and bought 0 shares, with a net sale of 949,389 shares. During the past 18 months, 2,607,334 shares of BeOne Medicines Ltd (ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,607,334 shares.
BeOne Medicines Ltd (ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.
BeOne Medicines Ltd Insider Transactions
Lai Wang Mailing Address
Above is the net worth, insider trading, and ownership report for Lai Wang. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Lai Wang's mailing address is: Grand Cayman.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
